PALMIERI, CLAUDIA
PALMIERI, CLAUDIA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.004 secondi).
Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
2025-01-01 Stefanizzi, Pasquale; Moscara, Lorenza; Palmieri, Claudia; Martinelli, Andrea; Fontanelli, Silvia; Bellomo, Cristina; Spinelli, Giuseppe; Tafuri, Silvio
Safety profile and medium- to long-term protection of the Recombinant Zoster Vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021-2025
2025-01-01 Stefanizzi, Pasquale; Moscara, Lorenza; Palmieri, Claudia; Martinelli, Andrea; Di Lorenzo, Antonio; Scaltrito, Chiara; Buonvino, Petra; Oliveto, Francesca; Pice, Giovanna; Marchisella, Laura; Spinelli, Giuseppe; Tafuri, Silvio
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23
2024-01-01 Stefanizzi, P; Moscara, L; Palmieri, C; Martinelli, A; Di Lorenzo, A; Venerito, V; Germinario, Ca; Tafuri, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024. | 1-gen-2025 | Stefanizzi, Pasquale; Moscara, Lorenza; Palmieri, Claudia; Martinelli, Andrea; Fontanelli, Silvia; Bellomo, Cristina; Spinelli, Giuseppe; Tafuri, Silvio | |
| Safety profile and medium- to long-term protection of the Recombinant Zoster Vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021-2025 | 1-gen-2025 | Stefanizzi, Pasquale; Moscara, Lorenza; Palmieri, Claudia; Martinelli, Andrea; Di Lorenzo, Antonio; Scaltrito, Chiara; Buonvino, Petra; Oliveto, Francesca; Pice, Giovanna; Marchisella, Laura; Spinelli, Giuseppe; Tafuri, Silvio | |
| Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23 | 1-gen-2024 | Stefanizzi, P; Moscara, L; Palmieri, C; Martinelli, A; Di Lorenzo, A; Venerito, V; Germinario, Ca; Tafuri, S |